Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Qiagen Gains SFDA Approval for HPV Test Aimed at Rural Areas

publication date: Nov 29, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Qiagen, the Dutch diagnostics company, has been granted SFDA approval for its careHPV Test. According to the company, the test is the first molecular diagnostic to screen for high-risk human papillomavirus (HPV) that is designed for resource-poor clinical settings – settings that lack electricity, water or a modern lab. The test can provide results during the patient’s visit. Qiagen will manufacture the test in its Shenzhen plant. More details....

Stock Symbol: (NSDQ: QGEN)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners